Latest:
A 'Whole Different Ballgame' for Myeloma Treatment
The BCMA protein has become the primary target for treating multiple myeloma, resulting in longer survival and more manageable side effects.
- About
- Advertise / Support
- Contact
- CancerNetwork.com
- TargetedOnc.com
- OncLive.com
- OncNursingNews.com
- Terms & Conditions
- Privacy
- Do Not Sell My Information
© 2024 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
Contributors
Jenny Burkholder
Latest:
One Nurse’s Devotion to Cancer Has Healed Many Patients
“I feel her strength, and because of Lorelei — the way she makes me feel comfortable and confident; the way she cares deeply for me, her other patients and colleagues; and her always professional attitude and manner — I realize that, like other obstacles, I will eventually be able to face this, too,” writes one nurse’s patient in an essay nominating her for CURE®’s 2022 Extraordinary Healer award.
Jennifer Cargile, Med, CCC-SLP
Jennifer Cargile, Med, CCC-SLP, is a speech-language pathologist at Cancer Treatment Centers of America Atlanta.
Latest:
Oncology Rehabilitation: An Integral Part of Integrative Care for Head and Neck Cancer Treatment
Head and neck cancer treatments and the subsequent side effects can be overwhelming for patients and their caregivers due to the impact they have on routine activities, writes a speech-language pathologist at Cancer Treatment Center of America Atlanta. However, the expert notes, there are plenty of specialists who can help improve patient quality of life.